You have full text access to this OnlineOpen article

Photodynamic therapy for circumscribed choroidal haemangioma

  1. Irène M. E. Landau,
  2. Björn Steen,
  3. Stefan Seregard

Article first published online: 17 OCT 2002

DOI: 10.1034/j.1600-0420.2002.800513.x

Issue

Acta Ophthalmologica Scandinavica

Acta Ophthalmologica Scandinavica

Volume 80, Issue 5, pages 531–536, October 2002

Additional Information

How to Cite

Landau, I. M. E., Steen, B. and Seregard, S. (2002), Photodynamic therapy for circumscribed choroidal haemangioma. Acta Ophthalmologica Scandinavica, 80: 531–536. doi: 10.1034/j.1600-0420.2002.800513.x

Author Information

  1. St. Eriks Eye Hospital, Karolinska Institute, Stockholm, Sweden

* Irène Landau St. Eriks Eye Hospital Polhemsgatan 50 SE-112 82 Stockholm Sweden Tel: + 46 8 67 23 061 Fax: + 46 8 67 23 375 Email: irene.landau@sankterik.se

Publication History

  1. Issue published online: 12 MAR 2003
  2. Article first published online: 17 OCT 2002
  3. Received on January 22nd, 2002.Accepted on May 23rd, 2002.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (363K)

Keywords:

  • choroidal haemangioma;
  • photodynamic therapy;
  • treatment;
  • visual acuity;
  • echography

ABSTRACT.

Purpose:  To assess the efficacy of photodynamic therapy (PDT) as a new treatment for circumscribed choroidal haemangioma (CCH).

Methods:  Eight patients with CCH were treated with PDT using a protocol similar to that used in the standard treatment of neovascular age-related macular degeneration.

Results:  Visual acuity improved in six of eight eyes, remained unchanged in one eye and deteriorated in one eye after 3–15 months (median 7 months) follow-up. Pre-treatment metamorphopsia disappeared in all but two cases. The thickness of the CCH measured with standardized echography showed marked regression within 1 month after PDT. In six eyes there was no remaining protrusion after PDT and one lesion was barely detectable. One patient experienced a transient choroidal effusion and perifoveal haemorrhage.

Conclusion:  Photodynamic therapy is a promising new treatment for CCH as it restores visual function in most cases without causing apparent ocular or systemic side-effects.

View Full Article (HTML) Get PDF (363K)